December 1, 2013
Safer Interventional Procedures with Toshiba's Industry-First Dose Tracking System
CHICAGO, Dec. 1, 2013 - For the first time ever clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba America Medical Systems, Inc.'s Dose Tracking System. FDA cleared on Toshiba's Infinix™-i cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures, the new technology is Toshiba's latest advancement in optimizing dose management to improve patient safety.
Toshiba's Dose Tracking System displays live and cumulative radiation exposure through an intuitive and color coded indicator on a 3D visual representation of the patient. The display shows where the radiation is being administered on the patient's body in real time. This alerts the clinician throughout a procedure to make quick and necessary changes to distribute the skin dose and minimize the potential risk of locally concentrated high exposure.
"We partnered with the State University of New York at Buffalo to design the Dose Tracking System as an easy-to-understand visual aid that allows hospitals to suppress radiation exposure," said David Sloop, director, X-ray Vascular Business Unit, Toshiba. "In addition to the Dose Tracking System, other dose management tools like Spot Fluoroscopy offer a more complete picture and better manage radiation exposure, making procedures safer for patients and staff. These dose reduction technologies combined with the Infinix-i's unmatched flexibility in system design offer a perfect solution for today's interventional procedures."
Toshiba will showcase the Dose Tracking System, Spot Fluoroscopy and an enhanced processor for the Infinix-i at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Dec. 1-6, 2013 (Booth #7330 North Hall, B).
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation's website at www.toshibamedicalsystems.com.
Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 210,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$61.7 billion). Visit Toshiba's website at www.toshiba.co.jp/index.htm.
* Infinix is a trademark of Toshiba Medical Systems Corporation.
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION